Glutathione (GSH) is a tripeptide (glutamate-cysteine-glycine) that serves as the cell's primary endogenous antioxidant. Parenteral glutathione is used in anti-aging, skin, and detoxification research protocols.
Glutathione directly reduces reactive oxygen species, is a cofactor for glutathione peroxidase and S-transferases (detox), and regenerates other antioxidants. Oral bioavailability is poor; parenteral administration bypasses this.
Commonly reported research ranges: 600–2400 mg per IV infusion; lower doses nebulized or subcutaneous.
Dose should always be individualized. Factors that influence it include bodyweight, research goal, tolerance, and specific compound batch. The information below is educational, not a prescription.
A widely used reconstitution for a 600 mg vial is 4 ml of bacteriostatic water. With a typical 600000 mcg dose this works out to the unit count shown in the calculator below.
Approximately 10 minutes (IV); very short in plasma.
This half-life informs how often Glutathione is typically dosed. Shorter half-lives usually mean more frequent dosing to maintain plasma levels; longer half-lives allow daily, weekly, or less-frequent administration depending on the compound.
This list reflects effects reported in available literature or user logs. It is not exhaustive. Adverse reactions should be discussed with a qualified clinician.
Lyophilized: refrigerated. Reconstituted: refrigerated, use same day (glutathione oxidizes rapidly once dissolved).
Not FDA approved for anti-aging or skin-lightening indications. Approved internationally and available via compounding for specific uses.
For clinical-trial and primary-literature context, start with the sources below. We prioritize official drug labels, ClinicalTrials.gov records, and PubMed-indexed literature when available.
Peptide Protocol logs every dose, calculates reconstitution for you, and keeps your full protocol on one calm screen.
See the app →Glutathione (GSH) is a tripeptide (glutamate-cysteine-glycine) that serves as the cell's primary endogenous antioxidant. Parenteral glutathione is used in anti-aging, skin, and detoxification research protocols.
Glutathione directly reduces reactive oxygen species, is a cofactor for glutathione peroxidase and S-transferases (detox), and regenerates other antioxidants. Oral bioavailability is poor; parenteral administration bypasses this.
Commonly reported ranges are 600–2400 mg per IV infusion; lower doses nebulized or subcutaneous. This is research information, not a recommendation — dosing should be individualized under clinical guidance.
Approximately 10 minutes (IV); very short in plasma. This influences how often it is administered.
A common approach is to add 4 ml of bacteriostatic water to a 600 mg vial. Use the reconstitution calculator for exact unit counts.
Flushing or transient nausea during rapid IV infusion; Injection-site reactions; Sulfur odor or taste (normal); Skin lightening has been associated with some hypersensitivity events in case reports.
Not FDA approved for anti-aging or skin-lightening indications. Approved internationally and available via compounding for specific uses.
Registered or published clinical-trial sources for Glutathione are listed in the references section below. Evidence depth varies widely by compound, so check the cited trial registries and primary literature before relying on any claim.
Sources listed above were used to verify the claims on this page. See our editorial policy for how we source information.
Educational use only. Peptide Protocol is an informational tool. Nothing on this page constitutes medical advice. Many peptides are prescription-only or restricted in your jurisdiction. Always consult a licensed healthcare professional before injecting any compound.